Plasma retinoids after topical use of retinaldehyde on human skin

Skin Pharmacology and Physiology

Volumn 9, Issue 5, 1996, Pages 322-326

  Sass, J O ^a   Masgrau, E ^b   Piletta, P A ^b   Nau, H ^a   Saurat, J H ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Retinaldehyde; Retinoid metabolites

Indexed keywords

RETINAL; RETINOIC ACID; RETINOID; RETINOL ESTER; RETINOL PALMITATE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RETINOL DEFICIENCY; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; RETINALDEHYDE; RETINOIDS; SKIN; SKIN ABSORPTION; VITAMIN A DEFICIENCY;

EID: 0029752552     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211436     Document Type: Article

References (15)

1. Underwood BA: Vitamin A in animals and human nutrition; in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids, Orlando, Academic Press, 1984. vol 1. pp 281-292.
2. Lakshman MR, Okoh Ch: Enzymatic conversion of all trans-β-carotenc to retinal, Methods Enzymol 1993; 214:256.
3. Goodman DS, Huang HS, Shiratori T: Mechanism of the biosynthesis of vitamin A from beta-carotene, J Biol Chem 1966;242:1929-1932.
4. Lakshman MR, Mychkovsky I, Att-lcscy M: Enzymatic conversion of all-trans-ß-carotcne to retinal by a cytosolic enzyme from rabbit and rat intestinal mucosa, Proc Natl Acad Sei USA 1989;86:9124-9128.
5. Siegenthaler G, Saurat J-H, Ponec M: Retinol and retinal metabolism: Relationship to the state of differentiation of cultured human kératinocytes, Biochem J 1990;268:371- 378.
6. Saurat J-H, Didierjean L, Masgrau E, Piletta PA, Jaconi S, Chatellard-Gruaz D, Gumovski D, Masouye I, Salomon D, Siegenthaler G: Topical retinaldehydc on human skin: Biologic effects and tolerance, J Invest Dermatol 1994;103:770-774.
7. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Sun SC: Reti-noic acid embryopathy, N Engl J Med 1985;313:837-841.
8. Nau H, Chahoud I, Dencker L, Lammer EJ, Scott WJ: Teratogenicity of vitamin A and retinoids; in Vitamin A in Health and Disease, New York, Dekker, 1994. pp 615-664.
9. Nau H: Embryotoxicity and teratogenicity of topical retinoic acid, Skin Pharmacol 1993;6(suppl):35-44.
10. Eckhoff C, Nau H: Identification and quantitation ofall-trans-and 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid in human plasma, J Lipid Res 1990;31:1445-1454.
11. Eckhoff C, Wittfoht W, Nau H, Slik-ker W: Characterization of oxidized and glucuronated metabolites of retinol in monkey plasma by thermospray liquid chromatography/mass spectrometry, Biomed Environ MassSpcctrom 1990;19:428-433.
12. Collins MD, Eckhoff C, Chahoud I, Bochert G, Nau H: 4-Mcthylpira-zole partially ameliorated the teratogenicity of retinol and reduced the metabolic formation of all-trans-re-tinoic acid in the mouse, Arch Toxicol 1992:66:652-659.
13. Chatellard-Gruaz D, Saurat J-H, Siegenthaler G: Metabolism of re-tinaldehyde by living cultured human kératinocytes (abstract), J Invest Dermatol 1994:102:599.
14. Sass JO, Didierjean L, Carraux P, Nau H, Saurat J-H: Metabolism of topical rctinaldehyde and retinol by mouse skin in vivo: Predominant formation of rctinyl esters and identification of 14-hydroxy-retro-reti-nol (abstract), J Invest Dermatol 1996; 106:944.
15. Buchan P, Eckhoff C, Caron D, Nau H, Shroot B, Schaefer H: Repeated topical administration of all-trans-retinoic acid and plasma levels of retinoic acid in humans, J Am Acad Dermatol 1994;30:428-434